Ramatercept (USAN/INN);
Ace-031

C3418H5188N928O1062S38

77440.9870

77489.89

GRGEAETREC IYYNANWELE RTNQSGLERC EGEQDKRLHC YASWRNSSGT IELVKKGCWL
DDFNCYDRQE CVATEENPQV YFCCCEGNFC NERFTHLPEA GGPEVTYEPP PTAPTGGGTH
TCPPCPAPEL LGGPSVFLFP PKPKDTLMIS RTPEVTCVVV DVSHEDPEVK FNWYVDGVEV
HNAKTKPREE QYNSTYRVVS VLTVLHQDWL NGKEYKCKVS NKALPVPIEK TISKAKGQPR
EPQVYTLPPS REEMTKNQVS LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF
FLYSKLTVDK SRWQQGNVFS CSVMHEALHN HYTQKSLSLS PGK
(Disulfide bridge: 10-40, 30-58, 65-84, 71-83, 85-90, 122-122', 125-125', 157-217, 263-321, 10'-40', 30'-58,' 65'-84', 71'-83', 85'-90', 157'-217', 263'-321'; Glycosylation sites: Asn-23, Asn-46, Asn-193)

Myostatin inhibitor

Treatment of diseases that involve loss of skeletal muscle mass, strength, integrity

MSTN [HSA:2660] [KO:K05497]